Lyka Labs Ltd - 500259 - Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period for which the report has been issued 31/03/2019 2Date of Report30/05/2019 3 Name of the Certifying Firm Kaushal Doshi & Associates 4 Name of the Certifying Individual Kaushal Doshi 5Membership TypeACS 6 Membership Number 32178 7 CP No. 13143 8 Whether any observations/qualification reported by the Secretarial Auditor ? Yes LYKA LABS LTD. - 500259 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayLYKA LABS LTD. 2CINL24230GJ1976PLC008738 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY 0 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: RajTrivedi Designation: Companysecretary EmailId: companysecretary@lykalabs.com Name of the Chief Financial Officer: YogeshBShah Designation: chieffinancialofficer EmailId: ybshah@lykalabs.com Date: 27/05/2019 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. Lyka Labs Ltd - 500259 - Outcome of Board Meeting
We reference to BSE Limited''s and National Stock Exchange of India Limited''s letters dated 6th February, 2019 regarding late submission of Shareholding pattern and Statement of Investor Complaints for the Quarter ended 31st December, 2018, we wish to inform that as advised by BSE Limited and National Stock Exchange of India Limited the said letters were placed before the Board at the meeting held today and the members of the Board after deliberation noted that the delay was beyond control of the Management of the Company, and emphasized that going forward prescribed timelines should be strictly adhered to as far as practically possible. Lyka Labs Ltd - 500259 - Outcome of Board Meeting
We would like to inform you that the Board of Directors at their Meeting held today i.e. 18th May, 2019, have decided to not go ahead with the Merger of Lyka Exports Limited with Lyka Labs Limited which was earlier proposed with effect from 1st April, 2017 by the Board of Directors. LYKA LABS LTD. - 500259 - 1.Audited Standalone Financial Results For The Fourth Quarter And Financial Year Ended 31St March, 2019 Along With Auditors Report. 2. Audited Consolidated Financial Results For The Financial Year Ended 31St March, 2019 Along With Auditors Report. 3. A Declaration On Unmodified Opinion For Standalone Financial Results For The Year Ended 31St March, 2019. 4. Statement On Impact Of Audit Qualification For Consolidated Financial Results For The Year Ended 31St March, 2019
Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015 and with respect to the above, we wish to inform you that the Board of Directors at their Meeting held today have adopted the Audited Standalone Financial Results for the Fourth Quarter and Financial Year ended 31st March, 2019 along with Auditor's Report and Audited Consolidated Financial Results for the Financial Year ended 31st March, 2019 along with Auditor's Report. The meeting commenced at 11.30 and concluded at 19.35 Lyka Labs Ltd - 500259 - Board Meeting Intimation for Consideration Of Audited Standalone And Consolidated Financial Results For The Fourth Quarter And Financial Year Ended 31St March, 2019.
LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2019 ,inter alia, to consider and approve Audited Standalone and Consolidated Financial Results for the Fourth Quarter and Financial Year ended 31st March, 2019. LYKA LABS LTD. - 500259 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Imitation is given pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015, regarding issue of Duplicate Shares certificates to the shareholder.Details are attached herewith. Lyka Labs Ltd - 500259 - Fund Raising By Issuance Of Debt Securities By Large Entities
Pursuant to SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 dated 26th November, 2018, in respect of fund raising by issuance of Debt Securities by Large Entity and disclosure and compliance thereof by such Large Corporate (LC), in this connection, we hereby confirm that our Company Lyka Labs Limited does not fall under the Large Corporate (LC) category as per framework provided in aforesaid Circular. Kindly take the same on your records. Lyka Labs Ltd - 500259 - Compliance Certificate Under Regulation 40 (9) Of SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015
As required under regulation 40 (9) of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, we attach herewith a copy of compliance certificate dated 26th April, 2019 issued by M/s. P. P. Shah & Co., Company Secretaries for the half year ended 31st March, 2019.